Rx Rundown: Avid Bioservices, Novo Nordisk, Zealand Pharma and more
Deals: CDMO Avid Bioservices will be taken private by GHO Capital Partners and Ampersand Capital Partners in a deal worth $1.1 billion. Acadia Pharmaceuticals sold its priority review voucher for $150 million. Haleon named Vistar Media, a location-based ad …